‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
Quality of Life on the Atezolizumab/Bevacizumab Combination for Metastatic Kidney Cancer: Highlights from ASCO 2018 (BMIC-054)
30
00:00:00
/ 00:02:19
30